bioRxivCancer Biology
Multistability and consequent phenotypic plasticity in AMPK-Akt double negative feedback loop in cancer cells
Abstract
Adaptation and survival of cancer cells to various stress and growth factor conditions is crucial for successful metastasis. A double-negative feedback loop between two serine/threonine kinases AMPK and Akt can regulate the adaptation of breast cancer cells to matrix-deprivation stress. This feedback loop can generate majorly two phenotypes or cell states: matrix detachment-triggered pAMPKhigh/ pAktlow state, and matrix (re)attachment-triggered pAkthigh/ pAMPKlow state. However, whether these two cell states can exhibit phenotypic plasticity and heterogeneity in a given cell population, i.e., whether they can co-exist and undergo spontaneous switching to generate the other subpopulation, remains unclear. Here, we develop a mechanism-based mathematical model that captures the set of experimentally reported interactions among AMPK and Akt. Our simulations suggest that the AMPK-Akt feedback loop can give rise to two co-existing phenotypes (pAkthigh/ pAMPKlow and pAMPKhigh/pAktlow) in specific parameter regimes. Next, to test the model predictions, we segregated these two subpopulations in MDA-MB-231 cells and observed that each of them was capable of switching to another in adherent conditions. Finally, the predicted trends are supported by clinical data analysis of TCGA breast cancer and pan-cancer cohorts that revealed negatively correlated pAMPK and pAkt protein levels. Overall, our integrated computational-experimental approach unravels that AMPK-Akt feedback loop can generate multistability and drive phenotypic switching and heterogeneity in a cancer cell population.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Feedback loops involving AMPK, ERK and TFEB in matrix detachment leads to non-genetic heterogeneity
Saurav Kumar, Sayoni Maiti, … Annapoorni Rangarajan·bioRxiv·May 13, 2026
- The Mixed Blessing of AMPK Signaling in Cancer Treatments
Mehrshad Sadria, Deokhwa Seo, Anita T. Layton·BMC CancerPeer-reviewed·Jan 25, 2022
- A PKM2-YAP reciprocal repartitioning modulates invasion of breast cancer cells
Mallar Banerjee, Mayank Pandhari, … Ramray Bhat·bioRxiv·Jul 10, 2025
- AMPK activation by metformin promotes survival of dormant ER+ breast cancer cells
R. A. Hampsch, J. D. Wells, … T. W. Miller·bioRxiv·Jan 21, 2020
- AMPK-Fyn signaling promotes Notch1 stability to potentiate hypoxia-induced breast cancer stemness and drug resistance
M. Lahiry, S. Kumar, … A. Rangarajan·bioRxiv·Apr 21, 2020
- A multiprotein signaling complex sustains AKT and mTOR/S6K activity necessary for the survival of cancer cells undergoing stress
O. Y. Teran Pumar, M. R. Zanotelli, … K. F. Wilson·bioRxiv·Jan 3, 2023